Pentland (Level 3)
Healthcare Infection Society
Sidlaw (Level 3)
This session will focus on the role of microbial diagnostics in infection medicine and aims to highlight recent developments in this regard in the specific clinical area of haematology-oncology. Infections in these highly immunosuppressed patients are broad in range with unique challenges for diagnosis and treatment.
Fintry (Level 3)
British Association for Sexual Health and HIV
Tinto (level 0)
Back by popular demand, we are delighted to announce the return of the Pediatric Interactive Case Session. This session will feature four cases demonstrating the subtle differences between infection presentations in children compared to adults. The presenters will not only seek the input of the audience through online voting, but you will also have the opportunity to match wits against a panel of paediatric infection 'experts'!
Facilitator: Stéphane Paulus (Oxford University Hospitals, UK)
Panel: Sanjay Patel (Southampton Children’s Hospital, UK), Jim Hatcher (Great Ormond Street Hospital for Children, UK), Stephen Hughes (Chelsea & Westminster NHS Trust, UK) and Laura Ferreras-Antolin (St George's University Hospitals NHS Foundation Trust, UK)
Sanjay Patel (Southampton Children’s Hospital, UK) & Stéphane Paulus (Oxford University Hospitals, UK)
Moorfoot (Level 0)
Presentations on how and why GAMSAS was developed, experience to date from BSAC team, an assessor and client organisation perspectives, and plans for future spread.
Pentland (Level 3)
James Tinsdeall: Phacoemulsification is a surgery used to restore vision in people with cataracts or clouding of the eye's lens. This type of cataract surgery uses ultrasonic waves to break the lens into tiny pieces, which are then suctioned out of the eye with a vacuum and over 10,000 phacoemulsification extractions of lenses were undertaken from 2017 to 2020. However, In the period from 2017 to 2020 the MHRA received 38 reports of particles found in the eye either during or after surgery. Investigation found that these particles were of various substances such as organic matter, crystalline material, fibres, or pieces of plastic. Guidance was produced to decrease risks associated with inadequate or improper cleaning and decontamination of phacoemulsification (phaco) handpieces. This presentation will provide an update on the work of a number of groups working together to high light the risks of inadequate cleaning, decontamination and sterilization of phaco handpieces.
Gerry McDonnell: Gerry is the vice president at Johnson and Johnson and has had a distinguished career specialising in decontamination and sterilisation of surgical instruments and devices. Decontamination of surgical instruments and equipment is reliant on manufacturer’s instructions and sterile services departments having the facilities and equipment in order to process surgical instruments accordingly. This can involve training and education of staff to undertake protocols to ensure that cleaning decontamination and sterilization are carried out to quality standards.
Dr McDonnell will discuss the different decontamination and sterilisation requirements in different countries and the standards that need to be applied. He will also discuss the challenges to companies to ensure that their instruments are decontaminated and sterilised to minimise risks associated with surgery to ensure that all patients are safe, regardless of the country and standards required.
Central Sterilising Club
Kilsyth (Level 0)
Session description: JOINTCASE: A national audit investigating the microbiological quality of air in operating theatres during joint replacement procedures.
SALVAGE: Systematic Assessment of Line infections Via Audit throughout Great Britain to Evaluate management (http://nitcollaborative.org.uk/wp/salvage/).
SinkBug: Antimicrobial resistance gene and pathogen burden in sinks in UK hospitals and associations with healthcare-associated infections, sink design and sink usage: a multi-centre prospective sampling study (http://nitcollaborative.org.uk/wp/sinkbug/).
The National Infection Teams Collaborative for Audit and Research
Lammermuir (Level -2)
The organising Societies will provide an overview of their publications. This will be followed by a Q&A Panel where members of the editorial teams will provide valuable insight and advice on academic publishing.
Healthcare Infection Society, Microbiology Society and British Infection Association
Kilsyth (Level 0)
Association for Clinical Biochemistry and Laboratory Medicine
Tinto (level 0)
In this session four real-life cases will be presented by infection trainees and discussed by our multidisciplinary expert panel. This session will provide insight into clinical reasoning and managing diagnostic uncertainty through a clinical, laboratory and infection control lens.
Panel: Harriet Hughes (Public Health Wales, UK), Rebecca Sutherland (Western General Hospital Edinburgh, UK), Kate Templeton (NHS Lothian, UK) and Lee Stewart (NHS Greater Glasgow & Clyde, UK)
British Infection Association
Moorfoot (Level 0)
British Society for Medical Mycology
Pentland (Level 3)
ESCMID Study Group for Nosocomial Infections
Fintry (Level 3)
Session description: This session will aim to explore the evidence supporting evidence base supporting the introduction of personalised antimicrobial dosing into clinical practice. The session will cover the following aims: - an understanding on the principles of pharmacokinetic / pharmacodynamic properties of common antimicrobials and how treatment can be optimised through posology and administration - critically evaluation the in vitro methods for antimicrobial susceptibility determination used in practice and how these impact on antimicrobial dosing - appraise the current evidence base supporting antimicrobial personalisation and the impact on treatment outcomes - build the case for and against routine antimicrobial dose adjustments in clinical practice as a response to the antimicrobial resistance pressuresUK Clinical Pharmacy Association
Sidlaw (Level 3)
UK Health Security Agency
Sidlaw (Level 3)
British Infection Association
Tinto (level 0)
While there has been a significant trend in managing infections in adults by shifting towards earlier IV-to-oral switches and shorter total antibiotic courses, this shift has not necessarily translated into paediatric practice. This discrepancy partly stems from the lack of high-quality research studies for many paediatric pathologies but also reflects clinicians' risk-averse behaviour. During this session, we will delve into the evidence supporting the adoption of early IV-to-oral switches and shorter antibiotic courses in children. Furthermore, we will guide delegates to the recently developed BSAC pediatric pathways (https://bsac.org.uk/paediatricpathways/), which offer clinicians clear, evidence-based guidance for managing common infections in children.British Society for Antimicrobial Chemotherapy
Moorfoot (Level 0)
Healthcare Infection Society
Fintry (Level 3)
Healthcare Infection Society
Pentland (Level 3)
Pentland (Level 3)
Healthcare Infection Society
Lammermuir (Level -2)
Haemophagocytic Lymphohistiocytosis (HLH) is a syndrome of profound and damaging immune dysregulation (hyperinflammation) with high mortality. HLH may be rarely a genetic,primary disease but more commonly is a secondary phenomenon and can affect people of all ages. Secondary HLH is triggered by infection (especially viral infection), malignancy (particularly lymphoma), rheumatic disease and treatments including immunotherapy and CART therapy. The pathology of HLH relates to persistent, self-perpetuating activation of macrophages and T-lymphocytes and the resulting cytokine storm damages tissue and causes multi-organ failure. Treatment of HLH is with immune suppression, initially steroids and IL-1 blockade for which there is now an NHSE commissioning policy. The hallmarks of HLH are the 3 Fs – persistent, high grade fever, falling blood counts (often heralded by thrombocytopaenia) and highly elevated ferritin. People with HLH can present to any medical speciality but especially to infectious diseases teams as the features of HLH are non-specific and often mirror those of sepsis. Early recognition of HLH and prompt treatment improves outcomes and this requires close multidisciplinary working. This session aims to provide an introduction to HLH and, using a format similar to a working MDT meeting with an MDT panel, takes a detailed approach to two cases to draw out the diagnostic and treatment approach to HLH. The session closes with advice about taking the learning back into attendees workplaces and signposting of useful resources.British Infection Association
Tinto (level 0)
British Infection Association
Kilsyth (Level 0)
This session will cover the latest research developments and innovation in antimicrobial resistance research. World leading experts will present their latest data which spans from the laboratory through to real-world and clinical applications.Microbiology Society
Pentland (Level 3)
This session will highlight lessons learned from the ongoing Coronavirus pandemic. The spread of COVID-19 has demonstrated an urgent need to evaluate our global levels of pandemic preparedness and the scale of response required in the event of future outbreaks including Disease X.Microbiology Society
Moorfoot (Level 0)
Scottish Microbiology Association
Fintry (Level 3)
The timely review of intravenous antimicrobials as part of the IV to PO switch (IVOS) program has been identified as a key strategy for antimicrobial stewardship teams. This forms part of the NHS England CQUIN for 2023/24 and has been included in the recent UKSHA National antimicrobial intravenous-to-oral switch (IVOS) criteria for early switch guidance (November 2022). This session will provide an overview of the IVOS strategies adopted across the UK including examples where they have been successfully implemented in to practice. The challenges of implementing such programmes and opportunities for future developments will be discussed also.UK Clinical Pharmacy Association
Sidlaw (Level 3)
AMR is recognised as an increasing threat to human health, as well as having significant socio-economic consequences. It is estimated that 28 million people could fall into poverty due to an increase in healthcare costs of up to US$ 1 trillion globally by 2050, with a disproportionate impact on low-income countries according to the WHO. Vaccines are considered to be an important tool against AMR for multiple reasons- including reduction of antibiotic use, prevention of disease-related complications (e.g. secondary infections), the potential for reaching populations with vaccination who have limited access to other types of healthcare, and the potential to impact individuals with higher biological risk factors for exposure to resistance. This session will address the concepts of vaccines for AMR and the modelling that supports this approach, with some examples of infectious diseases for which this approach has been shown to be beneficial.UK Clinical Vaccine Network
Kilsyth (Level 0)
Symposium from an international expert in clinical and diagnostic mycology, discussing why implementing antifungal stewardship (AFS) is more important than ever.
Dr Schelenz will share her own experience of implementing antifungal stewardship at Kings College Hospital in London, discuss key priorities and barriers to AFS, the importance of fungal diagnostics and give her top tips on how to set up an effective AFS programme in your own centre.
This meeting is intended for UK healthcare professionals only.
Lammermuir (Level -2)
Lunch will be provided in the adjacent exhibition hall and can be brought to this session. So join us for this networking session that will begin with a short presentation on ‘What I wish I’d known as a new consultant’. We will then breakout into roundtable groups to discuss key themes that may be of interest to anyone who has just started or will shortly be starting in a consultant role. Roundtable topics will include core topics e.g. job planning and appraisals, combined with ‘common problems faced as a new infection consultant’. Each round table group will be facilitated by a senior consultant.
Pentland (Level 3)
British Infection Association
Fintry (Level 3)
Sidlaw (Level 3)
Tinto (level 0)
Pentland (Level 3)
The Infection Science Award is an exchange scheme that facilitates the most promising trainee and early career presenters from the Federation of Infection Societies (FIS) Annual Conference (Infectious Disease Futures session) to present at the Microbiology Society Annual Conference (Infection Forum) and vice versa. The aim of the Award is to support the exchange of ideas between the two meetings and the career development of early career researchers and trainee scientists and doctors by exposing them to new audiences and networks.
Moorfoot (Level 0)
Symposium from an international expert in infection prevention and antimicrobial stewardship, discussing the ongoing challenge of dealing with infections caused by Carbapenemase Producing Enterobacterales (CPE) in the UK.
Dr Jenkins will share his own extensive experience in addressing the issues that these multidrug resistant pathogens present, from surveillance and diagnostics through to the management of infections and outbreaks, including understanding the wider impact they can have on healthcare resources.
This meeting is intended for UK healthcare professionals only.
Moorfoot (Level 0)
Sidlaw (Level 3)
British Infection Association
Pentland (Level 3)
Healthcare Infection Society
Fintry (Level 3)
The speakers in this session will highlight the importance and patient benefit of rapidly diagnosing of infections in real time. The session will explore differences between currently-used benchtop diagnostics versus new, rapid and accurate diagnostic technologies that are being developed by scientists today and will be used in clinic in the future.Microbiology Society
Tinto (level 0)
Society for Anaerobic Microbiology
Kilsyth (Level 0)
Welsh Microbiology Association
In this session, experienced speakers will guide you through the challenges of identifying and responding to specific needs and infection challenges facing refugees and asylum seekers. The session will focus particularly on healthcare delivery in European settings, and will include case studies of outbreak management and individual case management. There will be discussion of how to adapt and improve our knowledge, skills and healthcare systems to provide appropriate infection services for individuals and populations who have experienced forced migration.
British Infection Association